25 years of Bayesian methods in the pharmaceutical industry: a personal, statistical bummel.
Twenty-five years ago the use of Bayesian methods in Pharmaceutical R&D was non-existent. Today that is no longer true. In this paper I describe my own personal journey along the road of discovery of Bayesian methods to routine use in the pharmaceutical industry.
Grieve
Andrew P
AP
King's College London, Department of Public Health Sciences, London, UK. andy.grieve@kcl.ac.uk
D001499:Bayes Theorem; D018592:Cross-Over Studies; D004345:Drug Industry; D017850:Economics, Pharmaceutical; D006801:Humans; D012107:Research Design; D013810:Therapeutic Equivalency; D014116:Toxicology